AstraZeneca Plc’s Chief Executive Officer Pascal Soriot warned that trade tariffs are not the best way to manage pharmaceuticals and that drugmakers are calling for no additional US levies on ...

AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe has stepped up its defence spending ...

CEO Soriot said Europe must boost investment in pharma innovation or risk falling further behind the US in drug development.

AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said on Tuesday, asserting it would maintain its 2025 forecasts if the levies end up being ...

"Our company is firmly committed to investing and growing in the US," chief executive Pascal Soriot said in an earnings statement, which also reported that first-quarter profit rose by over 30 percent ...

Harvey Jones says investment brokers showed their love for AstraZeneca shares at the start of the year, but maybe wondering ...

AstraZeneca’s CEO Pascal Soriot has described 2017 as a “defining” year for the company, with a series of new products gaining traction and the worst of a series of patent losses in the past.

Sir Pascal Soriot is usually several steps ahead of the game, so always worth listening to. His latest red flag is that Europe is falling behind in healthcare innovation and manufacturing ...

AstraZeneca (AZN) CEO Pascal Soriot is not overly concerned about the threat of tariffs by the Trump administration on pharmaceuticals and said a more favorable corporate tax credit could motivate ...

AstraZeneca has rejoined PhRMA as it expands its “presence in the United States with significant investments in research, development and manufacturing,” Pascal Soriot, AZ’s CEO, said in a ...

0856 ET – AstraZeneca’s Chief Executive officer Pascal Soriot says Europe must boost investment into healthcare, as it has done with defense spending, amid what he calls a shifting world order.

"Our company is firmly committed to investing and growing in the US," chief executive Pascal Soriot said in an earnings statement, which also reported that first-quarter profit rose by over 30 ...